Exploring the Preclinical Profile & IND Journey of Dual Payload ADC CAN016 for HER2 Refractory Patients
- Laying out CAN016 preclinical profile including monkey tox data supporting dual payload ADC IND approval
- Contextualizing pre-IND filing approach as an emerging ADC modality, and strategy for HER2 refractory patient treatment
- Highlighting ongoing firstin- human development of CAN016 and potential impact in HER2 refractory patients resistant to Enhertu